Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events.
Expert Rev Clin Immunol. 2022 Mar;18(3):233-244. doi: 10.1080/1744666X.2022.2039630. Epub 2022 Feb 17.
Expert Rev Clin Immunol. 2022.
PMID: 35129033